Microsoft’s artificial intelligence tool BioEmu can predict the multiple conformational states of a protein, giving insight into how a protein moves and its potential function.

Reactions that alter organic scaffolds by a single atom are already proving useful, but time will tell if they’ll ...

A key patent for Merck’s blockbuster drug Keytruda will expire in 2028. The cancer therapy brought the company $29.5 billion last year. Keytruda may also face “ price setting ” from the Inflation ...

IR Japan Holdings, an investor relations firm, reports approximately 70 foreign activist companies operating in Japan as of ...

&EN senior editor Craig Bettenhausen reports from New York City, visiting the climate chemistry start-ups Aircela, which is ...

The company raised $54.5 million to make treatments that restore protein function in polycystic kidney disease ...